600211 西藏药业
交易中 03-19 14:19:02
资讯
新帖
简况
花旗:维持康哲药业“买入”评级 目标价上调至17.5港元
智通财经 · 03-18 11:29
花旗:维持康哲药业“买入”评级 目标价上调至17.5港元
西藏药业(600211.SH)发布2025年度业绩,归母净利润9.38亿元,同比下降10.78%
智通财经 · 03-12
西藏药业(600211.SH)发布2025年度业绩,归母净利润9.38亿元,同比下降10.78%
每周股票复盘:西藏药业(600211)回购金额达1.78亿元,占总股本1.24%
证券之星 · 03-08
每周股票复盘:西藏药业(600211)回购金额达1.78亿元,占总股本1.24%
西藏药业(600211)披露回购股份进展公告,3月2日股价下跌1.13%
证券之星 · 03-02
西藏药业(600211)披露回购股份进展公告,3月2日股价下跌1.13%
每周股票复盘:西藏药业(600211)子公司担保议案获股东会通过
证券之星 · 03-01
每周股票复盘:西藏药业(600211)子公司担保议案获股东会通过
西藏药业(600211)披露2026年第一次临时股东会决议公告,2月25日股价上涨1.51%
证券之星 · 02-25
西藏药业(600211)披露2026年第一次临时股东会决议公告,2月25日股价上涨1.51%
每周股票复盘:西藏药业(600211)回购金额达1.78亿元,占总股本1.24%
证券之星 · 02-08
每周股票复盘:西藏药业(600211)回购金额达1.78亿元,占总股本1.24%
西藏药业(600211)披露关于控股子公司提供担保的议案,2月5日股价上涨0.48%
证券之星 · 02-05
西藏药业(600211)披露关于控股子公司提供担保的议案,2月5日股价上涨0.48%
西藏药业(600211)披露回购股份进展公告,2月3日股价上涨1.09%
证券之星 · 02-03
西藏药业(600211)披露回购股份进展公告,2月3日股价上涨1.09%
每周股票复盘:西藏药业(600211)股份回购达总股本1.02%
证券之星 · 01-25
每周股票复盘:西藏药业(600211)股份回购达总股本1.02%
西藏药业(600211)披露股份回购达到1%的进展公告,1月20日股价下跌0.3%
证券之星 · 01-20
西藏药业(600211)披露股份回购达到1%的进展公告,1月20日股价下跌0.3%
每周股票复盘:西藏药业(600211)首次回购股份3800股,耗资16.33万元
证券之星 · 01-11
每周股票复盘:西藏药业(600211)首次回购股份3800股,耗资16.33万元
西藏药业(600211)披露为控股子公司提供担保进展公告,01月07日股价下跌0.32%
证券之星 · 01-07
西藏药业(600211)披露为控股子公司提供担保进展公告,01月07日股价下跌0.32%
西藏药业(600211)披露首次回购公司股份公告,1月5日股价上涨3.85%
证券之星 · 01-05
西藏药业(600211)披露首次回购公司股份公告,1月5日股价上涨3.85%
每周股票复盘:西藏药业(600211)拟回购1.7亿至2亿元股份
证券之星 · 01-02
每周股票复盘:西藏药业(600211)拟回购1.7亿至2亿元股份
西藏药业(600211)披露以集中竞价交易方式回购股份计划,12月29日股价下跌0.74%
证券之星 · 2025-12-29
西藏药业(600211)披露以集中竞价交易方式回购股份计划,12月29日股价下跌0.74%
每周股票复盘:西藏药业(600211)拟回购股份,康哲企业持股32.28%
证券之星 · 2025-12-28
每周股票复盘:西藏药业(600211)拟回购股份,康哲企业持股32.28%
西藏药业(600211)披露回购股份事项前十大股东持股情况,12月24日股价上涨0.02%
证券之星 · 2025-12-24
西藏药业(600211)披露回购股份事项前十大股东持股情况,12月24日股价上涨0.02%
公告精选︱江南新材:拟约3亿元投建高端铜基核心材料研发及产业化项目;西藏药业:拟斥资1.7亿元-2亿元回购股份
格隆汇 · 2025-12-18
公告精选︱江南新材:拟约3亿元投建高端铜基核心材料研发及产业化项目;西藏药业:拟斥资1.7亿元-2亿元回购股份
12月8日增减持汇总:西藏药业等3股增持 药明康德等11股减持(表)
新浪证券 · 2025-12-18
12月8日增减持汇总:西藏药业等3股增持 药明康德等11股减持(表)
加载更多
公司概况
公司名称:
西藏诺迪康药业股份有限公司
所属行业:
医药制造业
上市日期:
1999-07-21
主营业务:
西藏诺迪康药业股份有限公司的主营业务是生产、销售胶囊剂、生物制剂、颗粒剂、涂膜剂等。公司的主要产品是新活素、依姆多、诺迪康、十味蒂达胶囊、雪山金罗汉止痛涂膜剂、小儿双清颗粒。近年来,公司先后荣获“西藏自治区专精特新中小企业”“主板上市公司价值100强”“农业产业化国家重点龙头企业”、中国创新药价值排行榜双榜:“综合实力榜TOP50”与“生物药榜TOP20”“2025大健康卓越竞争力上市公司”,连续荣获“金牛最具投资价值奖”“上市公司董事会秘书履职评价4A评级”等多项荣誉。
发行价格:
6.00
{"stockData":{"symbol":"600211","market":"SH","secType":"STK","nameCN":"西藏药业","latestPrice":43.01,"timestamp":1773901142000,"preClose":44.11,"halted":0,"volume":3236883,"delay":0,"changeRate":-0.0249,"floatShares":322000000,"shares":322000000,"eps":2.5583,"marketStatus":"交易中","change":-1.1,"latestTime":"03-19 14:19:02","open":43.85,"high":44.08,"low":42.83,"amount":141000000,"amplitude":0.0283,"askPrice":43.03,"askSize":15,"bidPrice":43.01,"bidSize":9,"shortable":0,"etf":0,"ttmEps":2.5583,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773903600000},"marketStatusCode":2,"adr":0,"adjPreClose":44.11,"symbolType":"stock","openAndCloseTimeList":[[1773883800000,1773891000000],[1773896400000,1773903600000]],"highLimit":48.52,"lowLimit":39.7,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":322319196,"isCdr":false,"pbRate":3.74,"roa":"--","peRate":16.811945,"roe":"26.98%","epsLYR":2.91,"committee":0.594406,"marketValue":13863000000,"turnoverRate":0.01,"status":1,"floatMarketCap":13863000000},"requestUrl":"/m/hq/s/600211","defaultTab":"news","newsList":[{"id":"2620528572","title":"花旗:维持康哲药业“买入”评级 目标价上调至17.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620528572","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620528572?lang=zh_cn&edition=full","pubTime":"2026-03-18 11:29","pubTimestamp":1773804540,"startTime":"0","endTime":"0","summary":"花旗发布研报称,维持康哲药业(00867)“买入”评级,根据管理层最新对创新药快速增长的指引,该行上调2026及2027年收入预测1%及4%,每股盈利预测上调1%及13%;将目标价由16.6港元上调至17.5 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260318/c675372644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2618138455","title":"西藏药业(600211.SH)发布2025年度业绩,归母净利润9.38亿元,同比下降10.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618138455","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618138455?lang=zh_cn&edition=full","pubTime":"2026-03-12 18:05","pubTimestamp":1773309928,"startTime":"0","endTime":"0","summary":"智通财经APP讯,西藏药业(600211.SH)披露2025年年度报告,报告期公司实现营收29.82亿元,同比增长6.23%;归属于上市公司股东的净利润9.38亿元,同比下降10.78%;扣非净利润8.71亿元,同比增长1.48%;基本每股收益2.91元。公司拟向全体股东按每10股派发现金8.76元(含税)。报告期内,在宏观环境复杂多变、产业政策动态演进的背景下,深入贯彻董事会战略部署,积极适应新时期的新要求,提升内部管理水平、拓展销售渠道、挖掘市场潜力、注重人才培养和团队建设,坚持以公司战略目标和年度经营目标为指引,按计划有序开展各项经营工作,公司经营情况总体保持平稳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"西藏药业(600211.SH)发布2025年度业绩,归母净利润9.38亿元,同比下降10.78%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600211"],"gpt_icon":0},{"id":"2617266359","title":"每周股票复盘:西藏药业(600211)回购金额达1.78亿元,占总股本1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617266359","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617266359?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:09","pubTimestamp":1772910551,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘,西藏药业报收于42.43元,较上周的42.58元下跌0.35%。本周,西藏药业3月3日盘中最高价报42.78元。西藏药业当前最新总市值136.76亿元,在生物制品板块市值排名22/51,在两市A股市值排名1553/5190。本周关注点公司公告汇总:截至2026年2月底,公司累计回购股份4,000,058股,占总股本的1.24%,已支付总金额177,595,651.46元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2616356863","title":"西藏药业(600211)披露回购股份进展公告,3月2日股价下跌1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616356863","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616356863?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:56","pubTimestamp":1772463378,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘,西藏药业报收于42.1元,较前一交易日下跌1.13%,最新总市值为135.7亿元。西藏药业近日披露《关于回购股份的进展公告》。公告显示,公司于2025年12月18日召开董事会,审议通过以集中竞价交易方式回购股份的议案,回购资金总额不低于17,000万元且不高于20,000万元,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。回购股份拟用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600211","BK0033"],"gpt_icon":0},{"id":"2616843269","title":"每周股票复盘:西藏药业(600211)子公司担保议案获股东会通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2616843269","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616843269?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:14","pubTimestamp":1772302451,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,西藏药业报收于42.58元,较上周的41.74元上涨2.01%。本周,西藏药业2月25日盘中最高价报42.78元。本次股东会于2026年2月25日召开,采用现场与网络投票相结合方式,审议通过关于公司控股子公司提供担保的议案。表决结果显示,同意股数占参会股东所持表决权的99.71%,议案获通过,其中中小投资者对议案的同意率为81.86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2614033982","title":"西藏药业(600211)披露2026年第一次临时股东会决议公告,2月25日股价上涨1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614033982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614033982?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:21","pubTimestamp":1772029278,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘,西藏药业报收于42.45元,较前一交易日上涨1.51%,最新总市值为136.82亿元。该股当日开盘42.08元,最高42.78元,最低41.81元,成交额达1.26亿元,换手率为0.92%。近日,西藏药业发布《西藏诺迪康药业股份有限公司2026年第一次临时股东会决议公告》。公告显示,公司于2026年2月25日在成都召开2026年第一次临时股东会,出席会议的股东及代理人共446人,代表有表决权股份总数179,455,251股,占公司有表决权股份总数的55.6762%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500038071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"gpt_icon":0},{"id":"2609525592","title":"每周股票复盘:西藏药业(600211)回购金额达1.78亿元,占总股本1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609525592","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609525592?lang=zh_cn&edition=full","pubTime":"2026-02-08 01:50","pubTimestamp":1770486622,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,西藏药业报收于42.77元,较上周的42.4元上涨0.87%。本周,西藏药业2月6日盘中最高价报43.6元。截至2026年1月月底,公司累计回购股份4,000,058股,占公司总股本的1.24%,已支付总金额177,595,651.46元,回购最高价为45.98元/股,最低价为42.66元/股。截至公告日,公司及控股子公司对外担保总额为80,000万元,占最近一期经审计净资产的20.24%,无逾期担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2609301332","title":"西藏药业(600211)披露关于控股子公司提供担保的议案,2月5日股价上涨0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609301332","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609301332?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:36","pubTimestamp":1770302180,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘,西藏药业报收于42.17元,较前一交易日上涨0.48%,最新总市值为135.92亿元。该股当日开盘41.97元,最高42.33元,最低41.86元,成交额达1.01亿元,换手率为0.74%。近日,西藏药业发布《关于召开2026年第一次临时股东会的通知》。会议将审议《关于公司控股子公司提供担保的议案》,该议案将对中小投资者单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2608453877","title":"西藏药业(600211)披露回购股份进展公告,2月3日股价上涨1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608453877","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608453877?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:36","pubTimestamp":1770129380,"startTime":"0","endTime":"0","summary":"西藏诺迪康药业股份有限公司近日披露《关于回购股份的进展公告》。公告显示,公司于2025年12月18日召开董事会,审议通过以集中竞价交易方式回购股份的议案,回购资金总额不低于17,000万元且不高于20,000万元,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。本次回购股份用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2606234174","title":"每周股票复盘:西藏药业(600211)股份回购达总股本1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606234174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606234174?lang=zh_cn&edition=full","pubTime":"2026-01-25 01:49","pubTimestamp":1769276950,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,西藏药业报收于43.95元,较上周的43.79元上涨0.37%。本周,西藏药业1月21日盘中最高价报44.78元。西藏药业当前最新总市值141.66亿元,在生物制品板块市值排名22/51,在两市A股市值排名1529/5182。本次回购股份将用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2604111672","title":"西藏药业(600211)披露股份回购达到1%的进展公告,1月20日股价下跌0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604111672?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:24","pubTimestamp":1768919055,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘,西藏药业报收于43.9元,较前一交易日下跌0.3%,最新总市值为141.5亿元。该股当日开盘44.07元,最高44.21元,最低43.7元,成交额达1.1亿元,换手率为0.77%。公司近日发布公告称,西藏诺迪康药业股份有限公司于2025年12月18日召开董事会,审议通过以集中竞价交易方式回购股份的议案,回购资金总额不低于17,000万元且不高于20,000万元,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000039675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2602536510","title":"每周股票复盘:西藏药业(600211)首次回购股份3800股,耗资16.33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602536510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602536510?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:44","pubTimestamp":1768074249,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,西藏药业报收于44.96元,较上周的42.55元上涨5.66%。本周,西藏药业1月9日盘中最高价报44.98元。公司为全资子公司西藏诺迪康生物医药销售有限公司和控股子公司西藏诺迪康医药有限公司分别提供5119.71万元和10000万元的连带责任保证担保,上述担保事项在前期审批额度内,并已获得反担保。截至公告日,公司及控股子公司对外担保总额为80,000万元,占最近一期经审计净资产的20.24%,无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2601801820","title":"西藏药业(600211)披露为控股子公司提供担保进展公告,01月07日股价下跌0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801820?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:24","pubTimestamp":1767795863,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘,西藏药业报收于44.05元,较前一交易日下跌0.32%,最新总市值为141.98亿元。公司近日发布公告称,西藏诺迪康药业股份有限公司为全资子公司西藏诺迪康生物医药销售有限公司和控股子公司西藏诺迪康医药有限公司分别提供5119.71万元和10000万元的连带责任保证担保,担保事项已在前期审批额度内,且已获得反担保。截至公告日,公司及控股子公司对外担保总额为80,000万元,占最近一期经审计净资产的20.24%,无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700038943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2601988204","title":"西藏药业(600211)披露首次回购公司股份公告,1月5日股价上涨3.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601988204","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601988204?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:19","pubTimestamp":1767622759,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘,西藏药业报收于44.19元,较前一交易日上涨3.85%,最新总市值为142.43亿元。该股当日开盘42.54元,最高44.55元,最低42.42元,成交额达3.02亿元,换手率为2.14%。近日,西藏诺迪康药业股份有限公司发布关于首次回购公司股份的公告。本次回购基于2025年12月18日董事会审议通过的回购方案,回购资金总额预计为17,000万元至20,000万元,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日,回购股份拟用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"gpt_icon":0},{"id":"2600036399","title":"每周股票复盘:西藏药业(600211)拟回购1.7亿至2亿元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036399?lang=zh_cn&edition=full","pubTime":"2026-01-02 02:40","pubTimestamp":1767292819,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,西藏药业报收于42.11元,较上周的42.45元下跌0.8%。本周,西藏药业12月22日盘中最高价报42.61元。本周关注点公司公告汇总:西藏药业计划以1.7亿元至2亿元回购股份,价格不超55元/股。回购股份价格不超过55元/股,回购期限为董事会审议通过之日起不超过12个月。本次回购股份拟用于股权激励或员工持股计划,若三年内未能转让完毕,未转让部分将依法注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"gpt_icon":0},{"id":"2595795735","title":"西藏药业(600211)披露以集中竞价交易方式回购股份计划,12月29日股价下跌0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595795735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595795735?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:30","pubTimestamp":1767018637,"startTime":"0","endTime":"0","summary":"近日,西藏诺迪康药业股份有限公司发布关于以集中竞价交易方式回购股份的回购报告书。公告显示,公司计划以集中竞价方式回购股份,回购金额不低于17,000万元且不高于20,000万元,资金来源为公司自有资金。回购股份价格不超过55元/股,回购期限为董事会审议通过之日起不超过12个月。本次回购股份拟用于股权激励或员工持股计划,若三年内未能转让完毕,未转让部分将依法注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900038015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"gpt_icon":0},{"id":"2594244081","title":"每周股票复盘:西藏药业(600211)拟回购股份,康哲企业持股32.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594244081","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594244081?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:19","pubTimestamp":1766863149,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,西藏药业报收于42.11元,较上周的42.45元下跌0.8%。本周,西藏药业12月22日盘中最高价报42.61元。西藏药业当前最新总市值135.73亿元,在生物制品板块市值排名22/51,在两市A股市值排名1441/5178。本周关注点公司公告汇总:西藏药业拟以集中竞价方式回购股份,康哲企业持股32.28%为第一大股东。前十大股东与前十大无限售条件股东名单一致,其中西藏康哲企业管理有限公司持股104,043,393股,占比32.28%,为第一大股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0239","BK0033"],"gpt_icon":0},{"id":"2593347022","title":"西藏药业(600211)披露回购股份事项前十大股东持股情况,12月24日股价上涨0.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593347022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593347022?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:25","pubTimestamp":1766586328,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘,西藏药业报收于42.19元,较前一交易日上涨0.02%,最新总市值为135.99亿元。该股当日开盘42.12元,最高42.32元,最低41.95元,成交额达7025.49万元,换手率为0.52%。公司近日发布公告,披露了关于回购股份事项前十大股东和前十大无限售条件股东的持股情况。公告显示,西藏诺迪康药业股份有限公司于2025年12月18日召开董事会,审议通过以集中竞价交易方式回购股份的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400040823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0033","BK0239"],"gpt_icon":0},{"id":"2592900243","title":"公告精选︱江南新材:拟约3亿元投建高端铜基核心材料研发及产业化项目;西藏药业:拟斥资1.7亿元-2亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2592900243","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592900243?lang=zh_cn&edition=full","pubTime":"2025-12-18 23:54","pubTimestamp":1766073294,"startTime":"0","endTime":"0","summary":"古鳌科技:前实际控制人陈崇军犯操纵证券市场罪,被判处有期徒刑六年","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3398624","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["603124","BK0239","BK0214","BK0033","600211"],"gpt_icon":0},{"id":"2592890154","title":"12月8日增减持汇总:西藏药业等3股增持 药明康德等11股减持(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2592890154","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592890154?lang=zh_cn&edition=full","pubTime":"2025-12-18 21:59","pubTimestamp":1766066340,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 据统计,12月18日,盘后大中矿业、四川路桥、西藏药业披露增持情况。包括立达信、药明康德、飞龙股份、瑞晨环保、蠡湖股份、君实生物、奕东电子、华海诚科、博硕科技、安联锐视、大中矿业在内的11家A股上市公司披露减持情况。\n\n\n\n新浪声明:此消息系转载自新浪合作媒体,新浪网登载此文出于传递更多信息之目的,并不意味着赞同其观点或证实其描述。文章内容仅供参考,不构成投资建议。投资者据此操作,风险自担。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-12-18/doc-inhcfvmc8319448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1979443071.USD","LU1934453819.USD","LU1997244956.HKD","LU2495084118.USD","LU2125910500.SGD","02359","BK0239","LU2045819591.USD","LU1808992512.USD","LU0052750758.USD","BK1576","BK0033","LU2328871848.SGD","LU1046422090.SGD","LU1969619763.USD","LU0320764599.SGD","603259","LU1997245094.SGD","LU2242644610.SGD","LU0456842615.SGD","LU2488822045.USD","BK0216","LU1997245177.USD","LU0708995583.HKD","BK1583","600211","BK1141"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773901147240,"stockEarnings":[{"period":"1week","weight":0.0313},{"period":"1month","weight":0.0568},{"period":"3month","weight":0.0751},{"period":"6month","weight":-0.1438},{"period":"1year","weight":0.1751},{"period":"ytd","weight":0.0367}],"compareEarnings":[{"period":"1week","weight":-0.017},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.0481},{"period":"6month","weight":0.0636},{"period":"1year","weight":0.1846},{"period":"ytd","weight":0.0237}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏诺迪康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"42842人(较上一季度减少5.15%)","perCapita":"7523股","listingDate":"1999-07-21","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区A区广州路3号","registeredCapital":"32231万元","survey":" 西藏诺迪康药业股份有限公司的主营业务是生产、销售胶囊剂、生物制剂、颗粒剂、涂膜剂等。公司的主要产品是新活素、依姆多、诺迪康、十味蒂达胶囊、雪山金罗汉止痛涂膜剂、小儿双清颗粒。近年来,公司先后荣获“西藏自治区专精特新中小企业”“主板上市公司价值100强”“农业产业化国家重点龙头企业”、中国创新药价值排行榜双榜:“综合实力榜TOP50”与“生物药榜TOP20”“2025大健康卓越竞争力上市公司”,连续荣获“金牛最具投资价值奖”“上市公司董事会秘书履职评价4A评级”等多项荣誉。","listedPrice":6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"西藏药业(600211)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供西藏药业(600211)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"西藏药业,600211,西藏药业股票,西藏药业股票老虎,西藏药业股票老虎国际,西藏药业行情,西藏药业股票行情,西藏药业股价,西藏药业股市,西藏药业股票价格,西藏药业股票交易,西藏药业股票购买,西藏药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"西藏药业(600211)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供西藏药业(600211)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}